Pro Medicus (OTCMKTS:PMCUF) Sees Unusually-High Trading Volume – Here’s What Happened

Shares of Pro Medicus Limited (OTCMKTS:PMCUF) saw strong trading volume on Wednesday. 3,195 shares were traded during trading, an increase of 464% from the previous session’s volume of 566 shares. The stock last traded at $124.40 and had previously closed at $115.0991.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.00.

Pro Medicus Stock Performance

The company has a fifty day simple moving average of $120.36 and a 200-day simple moving average of $113.79.

Pro Medicus Company Profile

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its solutions are designed to help hospitals, radiology practices and other providers store, manage, view and distribute medical images and related clinical information.

The company’s principal platform is Visage 7, an enterprise imaging system developed and commercialized through its wholly owned subsidiary, Visage Imaging. The platform supports the review of diagnostic studies such as computed tomography, magnetic resonance imaging and other medical images, with an emphasis on enterprise-wide access, workflow efficiency and advanced visualization.

Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves healthcare customers in Australia, North America and Europe.